Table 2.
Cancer-related information.
| Total | |
| (N=63) | |
|
| |
| Cancer side (transverse colon excluded) | |
| Missing | 14 |
| Right | 28 (57.1%) |
| Left | 21 (42.9%) |
| Cancer location (transverse colon and rectosigmoid excluded) | |
| Missing | 17 |
| Right | 28 (60.9%) |
| Left | 11 (23.9%) |
| Rectum | 7 (15.2%) |
| Tumor size | |
| N | 47 |
| Mean (SD) | 200.0 (361.6) |
| Median | 35.0 |
| Q1, Q3 | 23.0, 90.0 |
| Range | (2.0-988.0) |
| Regional lymph node positive | |
| N | 38 |
| Mean (SD) | 0.9 (1.6) |
| Median | 0.0 |
| Q1, Q3 | 0.0, 1.0 |
| Range | (0.0-6.0) |
| Regional lymph node exam | |
| N | 54 |
| Mean (SD) | 12.6 (15.6) |
| Median | 8.5 |
| Q1, Q3 | 0.0, 19.0 |
| Range | (0.0-77.0) |
| Stage | |
| Missing | 2 |
| 0 | 3 (4.9%) |
| 1 | 20 (32.8%) |
| 2 | 10 (16.4%) |
| 3 | 13 (21.3%) |
| 4 | 15 (24.6%) |
| Follow-up years since cancer diagnosis | |
| N | 63 |
| Mean (SD) | 3.7 (4.7) |
| Median | 2.3 |
| Q1,Q3 | 0.6, 5.3 |